In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking Gray Market Peptides: So Much Hype, So Little Data BPC 157: The peptide with big claims and scant evidence STAT FDA Unapproved Drugs: The $7.5 Billion 505(b)(2) Opportunity Most Pharma Execs Are Ignoring DrugPatentWatch Transform Data into Market Domination